<DOC>
	<DOCNO>NCT01768182</DOCNO>
	<brief_summary>Objective : HIV infect individual present cluster condition activate injure vascular endothelium . The administration folates may exert beneficial effect endothelial function different population risk cardiovascular disease . The aim study determine effect 4 week folinic acid supplementation forearm vascular response reactive hyperemia HIV-infected people antiretroviral therapy . Methods : This prospective , randomize , double-blind , placebo-controlled trial compare effect 4 week daily ingestion 5 mg folinic acid ( n=15 ) placebo ( n=15 ) . Participants anti-retroviral therapy least 6 month enrollment , undetectable viral load , CD4 cell count &gt; 200 cells/mm3 . Vascular function evaluate venous occlusion plethysmography baseline 4 week , determination brachial artery reactive hyperemia , isosorbide dinitrate administration</brief_summary>
	<brief_title>Folinic Acid Vascular Reactivity HIV</brief_title>
	<detailed_description>Design participant This randomize , double-blind , placebo-controlled trial . Eligible participant individual know HIV disease accord Centers Disease Control revise criterion , age 18 , ART least 6 month , undetectable viral load ( le 50 copies/ml ) , CD4 count 200 cells/mm3 . Exclusion criterion diabetes mellitus , active infection , liver disease , renal disease , history cardiovascular disease , uncontrolled hypertension , pregnancy , use illicit drug mental illness would compromise understanding collaboration study . Patients currently use tobacco , take dietary supplement ( folic acid antioxidant ) woman take hormone replacement therapy also exclude . All medication regular use maintain throughout study period . The protocol approve committee ethic research Hospital de Clínicas de Porto Alegre , participant give write informed consent . Study settings The study take place HIV outpatient clinic Hospital de Clínicas de Porto Alegre , national reference center HIV/AIDS southern Brazil , August 2009 September 2011 . Interventions Participants randomly assign 4-week treatment either folinic acid ( n=15 ) placebo ( n=15 ) . The study supplementation regimen consist capsule contain 5 mg folinic acid placebo . Participants provide 1 bottle , contain 30 capsule . Subjects instruct take 1 capsule daily , morning . Outcomes The primary outcome measure assessment brachial artery vascular response reactive hyperemia . Secondary outcome change biochemical hemodynamic variable . Vascular measurement After overnight fast , assessment perform temperature-controlled ( 20-22°C ) , quiet room , subject supine position . Throughout protocol , blood pressure ( BP ) heart rate measure dominant arm use calibrate oscillometric automatic device ( Dinamap 1846 SX/P ; Critikon , Florida , USA ) . Forearm blood flow measure venous occlusion plethysmography ( D.E Hokanson , Washington , USA ) , nondominant limb , previously describe . In short , rapid inflator cuff use upper arm occlude venous outflow hand circulation arrest place cuff around wrist . Reactive hyperemia ( RH ) induce place cuff upper-arm 250 mmHg , release 5 min . All flow recording manually trace operator blind group , time . The reproducibility flow measurement laboratory intraday interday coefficient variation 6.9 9.2 % , respectively . After 15 min rest , 2.5 mg sublingual isosorbide dinitrate ( Isordil® , Sigma , Brazil ) , administer endothelium-independent vasodilator . Five minute later , endothelium-independent vasodilatation brachial artery measure . Laboratory measurement All sample obtain overnight fast , 4 week intervention . For subject , total plasma homocysteine concentration , serum folate , vitamin B12 , glucose , creatinine , total cholesterol , high density lipoprotein cholesterol ( HDL-C ) , triglyceride measure . Serum folate vitamin B12 level measure competitive immunoassay use direct chemiluminescent technology ( Bayer ADVIA Centaur , Leverkusen , Germany ) . Plasma homocysteine level also measure competitive immunoassay use direct chemiluminescent technology ( IMMULITE 2000 Siemens , Illinois , USA ) . Glucose , creatinine , total cholesterol , HDL-c , triglyceride measure standard laboratory method . Sample size randomization Power calculation show total number 15 participant per group would able detect change 4ml/min/100ml vascular response reactive hyperemia group , power 80 % α=0.05 . For allocation participant , randomization achieve computer-generated list random number , investigator remain blind study complete . Participants randomly assign placebo folinic acid treatment group . The randomization procedure perform three block 10 stratify accord sex , ensure relatively equal number men woman treatment group . Folinic acid placebo capsule indistinguishable shape , size , well color . They pre-packed identical bottle consecutively numbered patient , accord randomization schedule . Supplements cod neither investigator participant aware content . A person affiliate study one entrust identification code individually wrap bottle capsule . Statistical analysis All variable test normal distribution Kolmogorov-Smirnov test . Normally distributed variable express mean ± SEM . Variables non-normally distribute presented median ( 25th-75th percentile ) . Baseline comparison group characteristic carry unpaired t-test Mann-Whitney U test . To compare response 4 week intervention , two-way analysis variance ( ANOVA ) repeat measure ( group , time , interaction ) use . Associations change serum folic acid change RH association change plasma homocysteine change RH evaluate Spearman 's rank correlation coefficient . A two-tailed P value le 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>individual know HIV disease age 18 ART least 6 month undetectable viral load ( le 50 copies/ml ) CD4 count 200 cells/mm3 . diabetes mellitus active infection liver disease renal disease history cardiovascular disease uncontrolled hypertension pregnancy use illicit drug mental illness use tobacco take dietary supplement ( folic acid antioxidant ) woman take hormone replacement therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>folic acid ; folate ; Vascular Reactivity ; HIV</keyword>
</DOC>